Target intelligence / Profile preview

Cubilin-amnionless receptor (null)

Target
null
Molecular classification
Receptor, Membrane protein complex, Transporter
01

Overview

Vitamin B12 absorption is a multi-step process requiring the release of B12 from dietary proteins in the stomach, its complexation with haptocorrin (R-protein), transfer to intrinsic factor in the duodenum, and subsequent absorption in the distal ileum via binding of the B12–intrinsic factor complex to the cubilin-amnionless membrane receptor complex (cubam receptor) on enterocytes. Inherited or acquired defects in any component of this pathway can lead to B12 deficiency, affecting hematologic and neurologic health. While multiple proteins are involved, the most specific and druggable "target" for absorption in humans is the cubilin-amnionless receptor.

Other names
Cubam receptorCubilin–amnionless complexIF–cobalamin receptorCUBN-AMN complexIntrinsic factor–vitamin B12 receptor
02

Mechanism of action

For drugs affecting absorption (indirect): Inhibition of acid production (proton pump inhibitors) reduces B12 release from food. For supplement therapy: Providing vitamin B12 in very high doses permits passive diffusion, bypassing the receptor-mediated pathway.

03

Biological functions

Transport of vitamin B12 from the gut into enterocytesIntestinal absorptionNutrient uptake
04

Disease associations

Megaloblastic anemiaImerslund-Gräsbeck syndromePernicious anemiaMalabsorption syndromes
05

Safety considerations

Vitamin B12 malabsorption can lead to irreversible neurologic changes and severe anemiaLack of reliable absorption tests (Schilling test is obsolete)High-dose oral B12 generally has low risk, but underlying causes may require attention
06

Interacting drugs

Proton pump inhibitors

3 more in the full profile.

07

Biomarkers

Serum vitamin B12HolotranscobalaminMethylmalonic acidHomocysteine

Beyond the preview

Go deeper on Cubilin-amnionless receptor (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cubilin-amnionless receptor (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call